Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-02-20 @ 6:39 PM
Study NCT ID:
NCT03003468
Status:
COMPLETED
Last Update Posted:
2024-08-13
First Post:
2016-12-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
Sponsor:
Lawrence Feldman, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BTCRC-LUN15-017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None